Soligenix

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Soligenix and other ETFs, options, and stocks.

About SNGX

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments.

CEO

Christopher J. Schaber

CEOChristopher J. Schaber

Employees

Employees16

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1987

Founded1987

Employees

Employees16

SNGX Key Statistics

Market cap

6.20M

Market cap6.20M

Price-Earnings ratio

-0.44

Price-Earnings ratio-0.44

Dividend yield

—

Dividend yield—

Average volume

20.00K

Average volume20.00K

High today

$1.99

High today$1.99

Low today

$1.87

Low today$1.87

Open price

$1.93

Open price$1.93

Volume

13.10K

Volume13.10K

52 Week high

$14.83

52 Week high$14.83

52 Week low

$1.68

52 Week low$1.68

People also own

Based on the portfolios of people who own SNGX. This list is generated using Robinhood data, and it’s not a recommendation.

SNDL

Tilray Brands

Cenntro Inc.

Tonix Pharmaceuticals

NIO

Ocugen, Inc